Welcome to Ypsomed

Ypsomed is a worldwide leading independent developer and manufacturer of injection systems for custom-made self-administration and supplier of pen needles for the treatment of diabetes, growth disorders or infertility, as well as for further therapeutic areas. Ypsomed has well-established partnerships with numerous leading pharmaceutical and biotech companies such as Sanofi, Eli Lilly, Pfizer, Roche, Genentech, Merck Serono, Amylin, NPS and others.

Ypsomed is headquartered in Burgdorf, Switzerland, and employs approximately 1’050 employees at several production sites in Switzerland and throughout a European sales and distribution network.

Print versie | Top